Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Envafolimab (ASC 22; KN 035), a recombinant humanized single-domain anti-PD-L1 antibody, integrates the anti-PD-L1 domain with the Fc fragment of the human IgG1 antibody. It inhibits the PD-L1 and PD-1 interaction with an IC 50 of 5.25 nM, indicating its research potential for solid tumors [1] [2] [3].
説明 | Envafolimab (ASC 22; KN 035), a recombinant humanized single-domain anti-PD-L1 antibody, integrates the anti-PD-L1 domain with the Fc fragment of the human IgG1 antibody. It inhibits the PD-L1 and PD-1 interaction with an IC 50 of 5.25 nM, indicating its research potential for solid tumors [1] [2] [3]. |
分子量 | N/A |
CAS No. | 2102192-68-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Envafolimab 2102192-68-5 Inhibitor inhibitor inhibit